Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | MMP2 | P08253 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13355186 | 0.90 | LMNA (0.36) | SHBGNAAACHRM2CHRM4CHRM1 | |
| SCHEMBL1055162 | 0.85 | LMNA (0.43) | SHBGEPHX1NAAAEPHX2ALDH1A1 | |
| SCHEMBL1054941 | 0.85 | LMNA (0.43) | SHBGEPHX1NAAAEPHX2ALDH1A1 | |
| SCHEMBL25022787 | 0.85 | EPHX1 (0.38) | SHBGEPHX1CA12CA1CA2 | |
| SCHEMBL941154 | 0.85 | LMNA (0.43) | SHBGEPHX1NAAAEPHX2ALDH1A1 | |
| SCHEMBL2265095 | 0.84 | EPHX1 (0.38) | SHBGEPHX1CA12CA1CA2 | |
| SCHEMBL15219463 | 0.84 | SHBG (0.40) | SHBGEPHX1NAAAEPHX2CHRM2 | |
| SCHEMBL939671 | 0.84 | ROCK2 (0.35) | CHRM2CHRM4CHRM1CHRM3LMNA | |
| SCHEMBL10936420 | 0.82 | LMNA (0.48) | EPHX1NAAAEPHX2ALDH1A1LMNA | |
| SCHEMBL25021449 | 0.82 | EPHX1 (0.35) | SHBGEPHX1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12416114-B2 | Fabric spray containing lactilol for malodour reduction | CONIPCO, INC. (US) | 2025-09-16 | — | — | US | disclosed |
| EP-3694964-B1 | AQUEOUS SPRAY COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-08-06 | — | — | EP | disclosed |
| EP-3149143-B1 | USE OF POLYPEPTIDE | NOVOZYMES AS (DK) | 2025-08-06 | — | — | EP | disclosed |
| WO-2025078195-A1 | FABRIC SPRAY | UNILEVER IP HOLDINGS B.V. (NL) | 2025-04-17 | — | — | WO | disclosed |
| EP-3694965-B1 | AQUEOUS SPRAY COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-02-12 | — | — | EP | disclosed |
| CN-114901901-B | Fabric spray | 联合利华知识产权控股有限公司 | 2024-11-08 | — | — | CN | disclosed |
| EP-4278035-B1 | METHOD FOR SPRAYING LAUNDRY | UNILEVER IP HOLDINGS B V (NL) | 2024-10-23 | — | — | EP | disclosed |
| US-11987771-B2 | Fabric spray composition comprising a non-functionalized silicone nanoemulsion and peg-40 hydrogenated castor oil | CONOPCO, INC. (US) | 2024-05-21 | — | — | US | disclosed |
| US-20240141255-A1 | FABRIC SPRAY COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2024-05-02 | — | — | US | disclosed |
| EP-4211213-B1 | LAUNDRY SPRAY COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2024-04-03 | — | — | EP | disclosed |
| EP-1496949-A1 | MALODOR-CONTROLLING COMPOSITIONS COMPRISING ODOR CONTROL AGENTS AND MICROCAPSULES CONTAINING AN ACTIVE MATERIAL | THE PROCTER & GAMBLE COMPANY (US) | 2005-01-19 | — | — | EP | disclosed |
| EP-1495102-A2 | COMPOSITIONS COMPRISING A DISPERSANT AND MICROCAPSULES CONTAINING AN ACTIVE MATERIAL | THE PROCTER & GAMBLE COMPANY (US) | 2005-01-12 | — | — | EP | disclosed |
| WO-2003099981-A1 | METHODS AND ARTICLES FOR REDUCING AIRBORNE PARTICULATES | THE PROCTER & GAMBLE COMPANY (US) | 2003-12-04 | — | — | WO | disclosed |
| US-20030224030-A1 | Methods and articles for reducing airborne particulates | THE PROCTER & GAMBLE COMPANY | 2003-12-04 | — | — | US | disclosed |
| US-20030215417-A1 | Malodor-controlling compositions comprising odor control agents and microcapsules containing an active material | THE PROCTER & GAMBLE COMPANY | 2003-11-20 | — | — | US | disclosed |
| US-20030216488-A1 | Compositions comprising a dispersant and microcapsules containing an active material | THE PROCTER & GAMBLE COMPANY | 2003-11-20 | — | — | US | disclosed |
| WO-2003089561-A2 | COMPOSITIONS COMPRISING A DISPERSANT AND MICROCAPSULES CONTAINING AN ACTIVE MATERIAL | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-30 | — | — | WO | disclosed |
| WO-2003089019-A1 | MALODOR-CONTROLLING COMPOSITIONS COMPRISING ODOR CONTROL AGENTS AND MICROCAPSULES CONTAINING AN ACTIVE MATERIAL | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-30 | — | — | WO | disclosed |
| US-4719105-A | Method, compositions and compounds useful in room fresheners employing cyclohexyl alcohol and ester derivatives | BUSH BOAKE ALLEN, INC. (GB) | 1988-01-12 | — | — | US | disclosed |
| US-4622221-A | Method, compositions and compounds, useful in room fresheners employing cyclohexyl alcohol and ester derivatives | BUSH BOAKE ALLEN INC. (US) | 1986-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030224030-A1 | Methods and articles for reducing airborne particulates | CUTA, EXOSC9, PPARA | SHBG 2647/4885EPHX1 4055/4885CA12 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.